Aduhelm (Aducanumab-avwa)
- Medicine Name: Aduhelm
- Generic Name: Aducanumab-avwa
- Dosage Form & Strength: Injection: 170 mg/1.7 mL (100 mg/mL) and 300 mg/3 mL (100 mg/mL) in a single-dose vial
- Manufactured By: Biogen Inc.
Medical Uses
Aduhelm is an amyloid beta-directed antibody used for the treatment of Alzheimer’s disease (AD). Treatment with this therapeutic drug should be started in patients with mild cognitive impairment or mild dementia stage of disease. Kindly Call/WhatsApp: +91 9310090915.
Recommended Dosage: After an initial titration, the recommended dosage of aduhelm injection is 10 mg/kg. It is administered as an intravenous (IV) infusion over approximately 60 minutes every four weeks and at least 21 days apart.
In case of missed infusion, resume administration at the same dose as quickly as possible. Infusions are to be administered every four weeks and at least 21 days apart.
Warning & Precautions
- Aduhelm 170 mg therapy may cause amyloid related imaging abnormalities-edema (ARIA-E), which can be observed on MRI as brain edema or sulcal effusions, and amyloid related imaging abnormalities-hemosiderin deposition (ARIA-H), which includes microhemorrhage and superficial siderosis.
- Obtain recent (within 12 months) brain MRI prior to starting treatment. The safety of this medicine in patients with any pre-treatment localized superficial siderosis, 10 or more brain microhemorrhages, or with a brain hemorrhage of more than 1 cm within 12 months of therapy initiation has not been established.
- Brain MRIs need to be obtained before the 7th infusion (1’st dose of 10 mg/kg) and 12th infusion (6’th dose of 10 mg/kg) of aduhelm 300 mg to evaluate for the existence of asymptomatic ARIA. For patients with radiographic findings of ARIA, enhanced clinical vigilance is needed.
- Urticaria and angioedema were reported in 1 patient in the placebo-controlled time-span of Studies 1 and 2, and emerged during the infusion. Quickly discontinue the infusion upon the initial observation of any symptoms consistent with a hypersensitivity reaction, and start suitable therapy.
Documentation & Availability
What documents are required to import ADUHELM to India?
ADUHELM (aducanumab-avwa) injection can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patient’s diagnostic reports.
- Patient’s ID proof (issued by the Government of India).
How is the order confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from a doctor.
- Import permit if applicable.
Is ADUHELM available in India?
ADUHELM (aducanumab-avwa injection) is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
S S Healthcare (S S Healthcare) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input
- On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc.)
- Medicine Price.
- Finding Genuine and reliable source from Canada, Europe, USA and Australia
- Ensuring 100% transparency.
ADUHELM can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and import permit.
S S Healthcare (S S Healthcare) can facilitate the supply of ADUHELM (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)
Please contact +91-7575883015 | Toll-Free No: +91-7575883015 or write us at sshealthcare1012@gmail.com for Aduhelm injection price in India.
We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Sourcing & Delivery
S S Healthcare is able to source the ADUHELM (Cancer Treatment Medicines) from across the globe, and has the ability to supply. S S Healthcare offers its customers worldwide access to the best available treatment.
S S Healthcare is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
FAQ
What is the Generic Name for the trade name drug Aduhelm®?
Aducanumab-avwa is Generic Name for the trade name drug Aduhelm®.
What is the Manufacturer Name of Aduhelm®?
Aduhelm® is manufactured by Biogen Inc.
Is Aduhelm® approved by the FDA?
Yes, Aduhelm® is approved by the FDA. Date of first approval: June 07, 2021.
What is the dosage and form of Aduhelm® supplied?
Aduhelm® is supplied as Injection: 170 mg/1.7 mL (100 mg/mL) and 300 mg/3 mL (100 mg/mL) in a single-dose vial for intravenous administration.
What are the most common side effects of Aduhelm®?
Most common side effects of Aduhelm® are headache, ARIA-H superficial siderosis, superficial siderosis, ARIA-Edema, and ARIA-H microhemorrhage.
How much does Aduhelm® cost in India?
The cost of Aduhelm in India can vary. To procure this anti-Alzheimer drug legally, you can call or WhatsApp +91-7575883015 or send mail to sshealthcare1012@gmail.com.
What are the storage conditions of Aduhelm®?
Store unopened vials of Aduhelm in original carton until use to protect from light. Store in a refrigerator at 2°C-8°C (36°F-46°F). Neither freeze nor shake it.
Is it safe to buy Aduhelm® online in India?
Yes, one can buy Aduhelm online in India at the lowest price from the S S Healthcare if this medicinal product is not (yet) registered or available in their country. We can facilitate the supply of Aduhelm® through legal channels.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Email Address
Sshealthcare1012@gmail.com
+91 7575883015
Landline
079 48916267
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners, and S S Healthcare does not lay any claim on them. We only provide information.
